A retrospective study to assess incidence and survival outcome of hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation under strategy of prophylactic ursodiol and intravenous heparin or prostaglandin E1
Latest Information Update: 08 Feb 2021
At a glance
- Drugs Ursodeoxycholic acid (Primary) ; Glutathione; Heparin; Prostaglandin-E synthase inhibitors
- Indications Hepatic veno-occlusive disease; Veno-occlusive disorders
- Focus Therapeutic Use
Most Recent Events
- 08 Feb 2021 New trial record
- 01 Feb 2021 Results published in the Bone Marrow Transplantation